How many institutional investors hold MYGN?

4 tracked institutional investors disclosed a position in MYGN (MYRIAD GENETICS INC) in their most recent 13F filing.

Who is the largest institutional holder of MYGN?

Izzy Englander, Millennium Management, holds the largest disclosed position in MYGN, valued at $142M.

Where does this MYGN ownership data come from?

SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.

MYGN — MYRIAD GENETICS INC

Name: MYRIAD GENETICS INC (MYGN) — Institutional Ownership
Creator: InvestorLens
License: https://www.sec.gov/about/website-policies

Public company

For educational research only.InvestorLens analyzes public regulatory filings (SEC EDGAR, STOCK Act PTRs) that may be delayed by 45 days or more. Information shown is historical and is not financial, legal, or tax advice, nor a recommendation or solicitation to buy or sell any security. Always do your own research.

InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.

Sourced from SEC EDGAR public filings

Why are billionaires buying MYGN?

Built from public SEC filings and public economic data. Not a recommendation.

Confidence

Institutional Conviction

Strong distribution · 0 buying vs 1 selling last quarter

Macro Tailwind

Macro conditions are mixed for this sector

Why? — Evidence & Confidence ▾

Of 1 tracked investors who changed their MYGN position last quarter, 0 bought and 1 sold (0% buy-side). Macro conditions are mixed for this sector (Macro Tailwind 57/100 in a Contraction regime).

Supporting evidence

+4 tracked investors reported holding MYGN at their latest filing
+Macro Health is 57/100 in a Contraction regime — historically acceptable for this sectorsource

Contradicting evidence — always shown

−1 tracked investor reduced or exited last quarter (0 reduced, 1 sold out)
−13F data is disclosed up to 45 days after quarter end — positions may have changed since

Know the limits

· 13F disclosure lag (up to 45 days)
· Tracked investors are a sample, not the whole market
· Sector regime fit is a historical average, not a guarantee

Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 9/6/2026.

About MYRIAD GENETICS INC (MYGN)

MYRIAD GENETICS INC (MYGN) appears in the most recent 13F filings of 4 tracked institutional investors. The largest disclosed position is held by Izzy Englander (Millennium Management), valued at $142M. Across recent filings, tracked investors recorded 1 new positions, 2 increased, 2 reduced, and 1 exited. All data sourced from SEC 13F filings.

Smart Money Consensus™

Based on recent institutional activity in MYGN

/100

Mixed Activity

Added / Increased3

Reduced2

Exited1

BearishBullish

Crowded Trade Score™

How many top investors track MYGN

/100

Emerging Interest

4investors

A small number of top investors own this.

UndiscoveredCrowded

151015+

MYGN Ownership Composition

How MYRIAD GENETICS INC is held across tracked investor types, based on reported 13F positions.

Dominant Type

Multi-Strategy / Quant

99% of tracked value

Institutions

tracked investors

Total Reported

$48.5M

combined 13F value

Multi-Strategy / Quant99.5%
Macro0.5%

Multi-Strategy / Quant(3)

99.5%

Macro(1)

0.5%

Tracked investors currently reporting MYGN

Investor	Firm	Shares	Market value	% of portfolio	As of
Izzy Englander	Millennium Management	6.6M	$37.8M	0.01%	Jun 30, 2026
Ken Griffin	Citadel Advisors	1.6M	$9.1M	0.00%	Jun 30, 2026
Steve Cohen	Point72 Asset Management	238.8K	$1.4M	0.00%	Jun 30, 2026
Paul Tudor Jones	Tudor Investment Corp	44.7K	$255.1K	0.00%	Jun 30, 2026

Izzy EnglanderJun 30, 2026
Millennium Management
Shares
6.6M
Value
$37.8M
% Portfolio
0.01%
Ken GriffinJun 30, 2026
Citadel Advisors
Shares
1.6M
Value
$9.1M
% Portfolio
0.00%
Steve CohenJun 30, 2026
Point72 Asset Management
Shares
238.8K
Value
$1.4M
% Portfolio
0.00%
Paul Tudor JonesJun 30, 2026
Tudor Investment Corp
Shares
44.7K
Value
$255.1K
% Portfolio
0.00%

Recent activity

Investor	Action	Δ %	Current value	Filing date
Steve Cohen	Increased	26.71%	$29.1M	Nov 14, 2024
Steve Cohen	Reduced	-67.23%	$4.8M	Feb 14, 2025
Steve Cohen	Reduced	-46.93%	$1.6M	Jul 21, 2025
Steve Cohen	Increased	407.06%	$5M	Aug 14, 2025
Steve Cohen	Sold	-100.00%	$0	Nov 14, 2025
Steve Cohen	New	—	$20.5M	Sep 16, 2024

Steve Cohen
Increased
$29.1M(26.71%)Nov 14, 2024
Steve Cohen
Reduced
$4.8M(-67.23%)Feb 14, 2025
Steve Cohen
Reduced
$1.6M(-46.93%)Jul 21, 2025
Steve Cohen
Increased
$5M(407.06%)Aug 14, 2025
Steve Cohen
Sold
$0(-100.00%)Nov 14, 2025
Steve Cohen
New
$20.5MSep 16, 2024

Frequently asked questions

How many institutional investors hold MYGN?: 4 tracked institutional investors disclosed a position in MYGN (MYRIAD GENETICS INC) in their most recent 13F filing.
Who is the largest institutional holder of MYGN?: Izzy Englander, Millennium Management, holds the largest disclosed position in MYGN, valued at $142M.
Did institutional ownership of MYGN increase or decrease?: Across recent 13F filings, tracked investors recorded 1 new positions, 2 increased, 2 reduced, and 1 fully exited MYGN.
Where does this MYGN ownership data come from?: SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.